| 0.3 |
1.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
0.9 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.2 |
1.2 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.2 |
0.7 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
0.5 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.1 |
1.3 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.5 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.1 |
0.3 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.4 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
0.6 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 |
0.2 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
0.2 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.4 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.2 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.1 |
0.4 |
GO:0051036 |
regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.4 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.3 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
0.8 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.2 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
1.1 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.0 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.2 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.1 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 |
0.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.1 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.5 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.1 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.0 |
0.1 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.7 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.2 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.3 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.3 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.4 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 |
0.2 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.1 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.0 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.0 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.0 |
0.2 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.0 |
0.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.0 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) |
| 0.0 |
0.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.0 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.0 |
0.2 |
GO:0031272 |
regulation of pseudopodium assembly(GO:0031272) |
| 0.0 |
0.5 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.3 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.0 |
0.2 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.1 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.4 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.1 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.0 |
0.6 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.0 |
0.0 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.5 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 |
0.3 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
